down arrow

Albemarle Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US0126531013
USD
119.14
-7.35 (-5.81%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

117.61126.49

52 Week

49.43132.90
Valuation
Technical
Day's Volume

CASH

4.24 M

Shareholding (Mar 2025)

FII

21.19%

Held by 421 FIIs

DII

16.41%

Held by 78 DIIs

Promoter

0.07%

How big is Albemarle Corp.?

22-Jun-2025

As of Jun 18, Albemarle Corp. has a market capitalization of 7,023.18 million, with net sales of 5,093.66 million and a net profit loss of 1,102.82 million over the latest four quarters. Shareholder's funds are at 9,961.52 million, and total assets amount to 16,609.65 million.

As of Jun 18, Albemarle Corp. has a market capitalization of 7,023.18 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the company reported net sales of 5,093.66 million for the latest four quarters. However, it experienced a net profit loss of 1,102.82 million during the same period.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds at 9,961.52 million and total assets amounting to 16,609.65 million.

Read More

What does Albemarle Corp. do?

22-Jun-2025

Albemarle Corporation is a global developer and manufacturer of specialty chemicals, classified as a mid-cap company with a market cap of approximately $7 billion. As of March 2025, it reported net sales of $1.077 billion and a net profit of $49 million.

Overview:<BR>Albemarle Corporation is a global developer, manufacturer, and marketer of highly-engineered specialty chemicals, operating within the specialty chemicals industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,077 Million (Quarterly Results - Mar 2025)<BR>- Net Profit: 49 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 7,023.18 Million (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 7,040.00<BR>- Dividend Yield: 203.69%<BR>- Debt Equity: 0.19<BR>- Return on Equity: 0.00%<BR>- Price to Book: 0.70<BR><BR>Contact Details:<BR>- Address: 4250 Congress St Ste 900, CHARLOTTE NC: 28209-4615<BR>- Tel: ['1 980 2995700', '1 980 2995641']<BR>- Fax: 1 225 3887686<BR>- Website: http://www.albemarle.com/Home-3.html

Read More

Who are in the management team of Albemarle Corp.?

22-Jun-2025

As of March 2022, the management team of Albemarle Corp. includes Jerry Masters as Chairman, President, and CEO, with James O'Brien as Lead Independent Director and independent directors Mary Brlas, Glenda Minor, Diarmuid O'Connell, and Dean Seavers.

As of March 2022, the management team of Albemarle Corp. includes Mr. Jerry Masters, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the board features Mr. James O'Brien as the Lead Independent Director, along with independent directors Ms. Mary Brlas, Ms. Glenda Minor, Mr. Diarmuid O'Connell, and Mr. Dean Seavers.

Read More

Is Albemarle Corp. overvalued or undervalued?

20-Sep-2025

As of July 31, 2024, Albemarle Corp. is considered risky and overvalued with a P/E ratio of 7040 and an EV to EBITDA of 56.37, significantly higher than its peers, and has underperformed the S&P 500 with a year-to-date return of -5.98%.

As of 31 July 2024, the valuation grade for Albemarle Corp. has moved from expensive to risky, indicating a shift in perception regarding its investment attractiveness. The company appears to be overvalued based on its current metrics, particularly highlighted by a P/E ratio of 7040 and an EV to EBITDA of 56.37, which are significantly higher than its peers. Additionally, the Price to Book Value stands at 0.70, suggesting that the market may not be valuing the company's assets appropriately.<BR><BR>In comparison to its peers, Westlake Corp. has a P/E ratio of 82.20 and EV to EBITDA of 9.98, while Avantor, Inc. shows a more favorable P/E of 11.82 and EV to EBITDA of 11.86, indicating that Albemarle's valuation is not justified when looking at industry standards. Furthermore, Albemarle's stock has underperformed relative to the S&P 500, with a year-to-date return of -5.98% compared to the index's 12.22%, reinforcing the notion that the stock may be overvalued in the current market environment.

Read More

Is Albemarle Corp. technically bullish or bearish?

20-Sep-2025

As of September 10, 2025, Albemarle Corp. shows a mildly bullish technical trend, supported by positive MACD and moving averages, but has significantly underperformed the S&P 500 with a year-to-date return of -5.98% compared to 12.22%.

As of 10 September 2025, the technical trend for Albemarle Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is mildly bullish, supporting the positive shift. The daily moving averages are also bullish, while the weekly Bollinger Bands indicate a bullish stance, although the monthly view is bearish. The KST is bullish on a weekly basis and mildly bullish monthly, and the OBV shows a mildly bullish trend in both time frames. <BR><BR>Despite this mildly bullish technical stance, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -5.98% versus the S&P 500's 12.22%, and a 3-year return of -71.83% compared to the S&P 500's 70.41%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 8.81

 
2

The company has declared Negative results for the last 7 consecutive quarters

3

Risky - Negative Operating Profits

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 9,650 Million (Small Cap)

stock-summary
P/E

7,040.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

148.24%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

-0.92%

stock-summary
Price to Book

0.94

Revenue and Profits:
Net Sales:
1,330 Million
(Quarterly Results - Jun 2025)
Net Profit:
35 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
50.3%
0%
50.3%
6 Months
99.56%
0%
99.56%
1 Year
16.11%
0%
16.11%
2 Years
-0.7%
0%
-0.7%
3 Years
-58.09%
0%
-58.09%
4 Years
-52.62%
0%
-52.62%
5 Years
-14.42%
0%
-14.42%

Albemarle Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Albemarle Corp. Hits Day High with 8.5% Surge in Stock Price

Albemarle Corp. Hits Day High with 8.5% Surge in Stock Price

Albemarle Corp. has seen a notable increase in stock performance, contrasting with the S&P 500's modest gains. Despite recent upticks, the company has faced ongoing challenges, including declining net sales and profits over the past quarters, alongside a significant long-term performance decline compared to the broader market.

Read More
Albemarle Corp. Hits Day High with Strong 7.21% Intraday Surge

Albemarle Corp. Hits Day High with Strong 7.21% Intraday Surge

Albemarle Corp., a small-cap specialty chemicals company, saw a significant intraday gain, contrasting with a decline in the S&P 500. Despite recent positive trends, the company has faced challenges over the past year, reporting consecutive quarterly losses and declining net sales and profits. Its market cap is USD 9,650 million.

Read More
Albemarle Corp. Hits Day Low of $79.30 Amid Price Pressure

Albemarle Corp. Hits Day Low of $79.30 Amid Price Pressure

Albemarle Corp., a small-cap specialty chemicals company, saw its stock decline significantly amid ongoing challenges. Over the past year, net sales dropped by 29.31%, and net profit fell by 83.03%. The company has reported negative results for seven consecutive quarters, underperforming against the S&P 500.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.15%
EBIT Growth (5y)
-182.59%
EBIT to Interest (avg)
8.81
Debt to EBITDA (avg)
4.11
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.56
Tax Ratio
5.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
9.46%
ROE (avg)
12.35%
Valuation key factors
Factor
Value
P/E Ratio
7040
Industry P/E
Price to Book Value
0.70
EV to EBIT
-19.14
EV to EBITDA
56.37
EV to Capital Employed
0.75
EV to Sales
1.76
PEG Ratio
NA
Dividend Yield
269.21%
ROCE (Latest)
-3.92%
ROE (Latest)
0.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 147 Schemes (62.3%)

Foreign Institutions

Held by 421 Foreign Institutions (21.19%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 23.50% vs -12.57% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -28.60% vs -42.07% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,330.00",
          "val2": "1,076.90",
          "chgp": "23.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "222.50",
          "val2": "181.20",
          "chgp": "22.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49.90",
          "val2": "49.00",
          "chgp": "1.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.70",
          "val2": "44.00",
          "chgp": "-112.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "35.20",
          "val2": "49.30",
          "chgp": "-28.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.40%",
          "val2": "16.30%",
          "chgp": "2.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -44.08% vs 31.38% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -167.97% vs -40.66% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,377.50",
          "val2": "9,617.20",
          "chgp": "-44.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-39.80",
          "val2": "671.10",
          "chgp": "-105.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "165.60",
          "val2": "116.10",
          "chgp": "42.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,185.20",
          "val2": "171.30",
          "chgp": "-791.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,135.50",
          "val2": "1,670.50",
          "chgp": "-167.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-117.30%",
          "val2": "25.10%",
          "chgp": "-14.24%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,330.00
1,076.90
23.50%
Operating Profit (PBDIT) excl Other Income
222.50
181.20
22.79%
Interest
49.90
49.00
1.84%
Exceptional Items
-5.70
44.00
-112.95%
Consolidate Net Profit
35.20
49.30
-28.60%
Operating Profit Margin (Excl OI)
40.40%
16.30%
2.41%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 23.50% vs -12.57% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -28.60% vs -42.07% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,377.50
9,617.20
-44.08%
Operating Profit (PBDIT) excl Other Income
-39.80
671.10
-105.93%
Interest
165.60
116.10
42.64%
Exceptional Items
-1,185.20
171.30
-791.89%
Consolidate Net Profit
-1,135.50
1,670.50
-167.97%
Operating Profit Margin (Excl OI)
-117.30%
25.10%
-14.24%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -44.08% vs 31.38% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -167.97% vs -40.66% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Albemarle Corp. stock-summary
stock-summary
Albemarle Corp.
Specialty Chemicals
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.
Company Coordinates stock-summary
Company Details
4250 Congress St Ste 900 , CHARLOTTE NC : 28209-4615
stock-summary
Tel: 1 980 29957001 980 2995641
stock-summary
http://www.albemarle.com/Home-3.html
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."